Latest biopharmaceutical Stories
SAN DIEGO, Oct. 3, 2014 /PRNewswire/ -- Sorrento Therapeutics, Inc.
SAN DIEGO, Oct. 3, 2014 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that the U.S.
Finalists are announced for eight awards covering collaborations, business strategies, and social corporate responsibility and upstream, downstream and analytical technology applications.
-- Primary endpoint was met for 50 mg twice daily dosing -- FREMONT, Calif., Oct. 1, 2014 /PRNewswire/ -- Ardelyx, Inc.
ROCKVILLE, Md., Sept. 30, 2014 /PRNewswire/ -- RegeneRx Biopharmaceuticals, Inc.
CHENGDU, China, Sept. 29, 2014 /PRNewswire/ -- Tianyin Pharmaceutical Co., Inc.
SUNNYVALE, Calif. and SURESNES, France, Sept. 25, 2014 /PRNewswire/ -- Pharmacyclics, Inc.
NEW YORK, Sept.
Name Changed to PlasmaTech Biopharmaceuticals, Inc. DALLAS and NEW YORK, Sept. 22, 2014 /PRNewswire/ -- ACCESS PHARMACEUTICALS, INC.
- The parings of haberdine; also, any kind of fragments.